SEC Insider Transactions from Sukhtian Faisal Ghiath.

Last updated: 2026-03-14 11:29 UTC | Total transactions: 9

Sukhtian Faisal Ghiath has filed 9 insider transactions across 1 company since March 2023.

Most recent transaction: a grant/award of 117296 shares of Outlook Therapeutics, Inc. ($OTLK) on October 03, 2025.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Oct. 3, 2025 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Director A Stock Option (Right to Buy) 117296 $0.00 117,296.0000 34,796,120 9999.99% 0.34%
Oct. 1, 2025 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Director A Stock Option (Right to Buy) 286734 $0.00 286,734.0000 34,796,120 9999.99% 0.82%
Feb. 4, 2025 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Not found A Stock Option (Right to Buy) 12323 $0.00 12,323.0000 24,233,957 9999.99% 0.05%
Oct. 1, 2024 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Not found A Stock Option (Right to Buy) 56636 $0.00 56,636.0000 18,548,813 9999.99% 0.31%
Oct. 1, 2024 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Not found A Stock Option (Right to Buy) 134430 $0.00 134,430.0000 18,548,813 9999.99% 0.72%
Oct. 3, 2024 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Not found A Stock Option (Right to Buy) 19771 $0.00 19,771.0000 18,548,813 9999.99% 0.11%
March 7, 2024 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Not found A Stock Option (Right to Buy) 94441 $0.00 94,441.0000 13,012,833 9999.99% 0.73%
Oct. 4, 2023 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Director A Stock Option (Right to Buy) 372671 $0.00 372,671.0000 12,508,817 9999.99% 2.98%
March 29, 2023 Outlook Therapeutics, Inc. $OTLK Sukhtian Faisal Ghiath Director A Stock Option (Right to Buy) 41065 $0.00 41,065.0000 227,410,533 9999.99% 0.02%